310 related articles for article (PubMed ID: 31263116)
1. Repeatability of Multiparametric Prostate MRI Radiomics Features.
Schwier M; van Griethuysen J; Vangel MG; Pieper S; Peled S; Tempany C; Aerts HJWL; Kikinis R; Fennessy FM; Fedorov A
Sci Rep; 2019 Jul; 9(1):9441. PubMed ID: 31263116
[TBL] [Abstract][Full Text] [Related]
2. Reliability of MRI radiomics features in MR-guided radiotherapy for prostate cancer: Repeatability, reproducibility, and within-subject agreement.
Xue C; Yuan J; Poon DM; Zhou Y; Yang B; Yu SK; Cheung YK
Med Phys; 2021 Nov; 48(11):6976-6986. PubMed ID: 34562286
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric MRI and auto-fixed volume of interest-based radiomics signature for clinically significant peripheral zone prostate cancer.
Bleker J; Kwee TC; Dierckx RAJO; de Jong IJ; Huisman H; Yakar D
Eur Radiol; 2020 Mar; 30(3):1313-1324. PubMed ID: 31776744
[TBL] [Abstract][Full Text] [Related]
4. Objective risk stratification of prostate cancer using machine learning and radiomics applied to multiparametric magnetic resonance images.
Varghese B; Chen F; Hwang D; Palmer SL; De Castro Abreu AL; Ukimura O; Aron M; Aron M; Gill I; Duddalwar V; Pandey G
Sci Rep; 2019 Feb; 9(1):1570. PubMed ID: 30733585
[TBL] [Abstract][Full Text] [Related]
5. A dynamic-static combination model based on radiomics features for prostate cancer using multiparametric MRI.
Li S; Zheng T; Fan Z; Qu H; Wang J; Bi J; Lv Q; Zhang G; Cui X; Zhao Y
Phys Med Biol; 2022 Dec; 68(1):. PubMed ID: 36541844
[No Abstract] [Full Text] [Related]
6. Development and validation of a multiparametric MRI-based radiomics signature for distinguishing between indolent and aggressive prostate cancer.
Zhang L; Jiang D; Chen C; Yang X; Lei H; Kang Z; Huang H; Pang J
Br J Radiol; 2022 Mar; 95(1131):20210191. PubMed ID: 34289319
[TBL] [Abstract][Full Text] [Related]
7. Stratification of prostate cancer patients into low- and high-grade groups using multiparametric magnetic resonance radiomics with dynamic contrast-enhanced image joint histograms.
Urakami A; Arimura H; Takayama Y; Kinoshita F; Ninomiya K; Imada K; Watanabe S; Nishie A; Oda Y; Ishigami K
Prostate; 2022 Feb; 82(3):330-344. PubMed ID: 35014713
[TBL] [Abstract][Full Text] [Related]
8. The impact of pre-processing and disease characteristics on reproducibility of T2-weighted MRI radiomics features.
Dewi DEO; Sunoqrot MRS; Nketiah GA; Sandsmark E; Giskeødegård GF; Langørgen S; Bertilsson H; Elschot M; Bathen TF
MAGMA; 2023 Dec; 36(6):945-956. PubMed ID: 37556085
[TBL] [Abstract][Full Text] [Related]
9. An annotated test-retest collection of prostate multiparametric MRI.
Fedorov A; Schwier M; Clunie D; Herz C; Pieper S; Kikinis R; Tempany C; Fennessy F
Sci Data; 2018 Dec; 5():180281. PubMed ID: 30512014
[TBL] [Abstract][Full Text] [Related]
10. Influence of Image Processing on Radiomic Features From Magnetic Resonance Imaging.
Wichtmann BD; Harder FN; Weiss K; Schönberg SO; Attenberger UI; Alkadhi H; Pinto Dos Santos D; Baeßler B
Invest Radiol; 2023 Mar; 58(3):199-208. PubMed ID: 36070524
[TBL] [Abstract][Full Text] [Related]
11. The role of radiomics in prostate cancer radiotherapy.
Delgadillo R; Ford JC; Abramowitz MC; Dal Pra A; Pollack A; Stoyanova R
Strahlenther Onkol; 2020 Oct; 196(10):900-912. PubMed ID: 32821953
[TBL] [Abstract][Full Text] [Related]
12. Can we use radiomics in ultrasound imaging? Impact of preprocessing on feature repeatability.
Duron L; Savatovsky J; Fournier L; Lecler A
Diagn Interv Imaging; 2021 Nov; 102(11):659-667. PubMed ID: 34690106
[TBL] [Abstract][Full Text] [Related]
13. In Vivo Repeatability and Multiscanner Reproducibility of MRI Radiomics Features in Patients With Monoclonal Plasma Cell Disorders: A Prospective Bi-institutional Study.
Wennmann M; Bauer F; Klein A; Chmelik J; Grözinger M; Rotkopf LT; Neher P; Gnirs R; Kurz FT; Nonnenmacher T; Sauer S; Weinhold N; Goldschmidt H; Kleesiek J; Bonekamp D; Weber TF; Delorme S; Maier-Hein K; Schlemmer HP; Götz M
Invest Radiol; 2023 Apr; 58(4):253-264. PubMed ID: 36165988
[TBL] [Abstract][Full Text] [Related]
14. Repeatability of radiomic features in magnetic resonance imaging of glioblastoma: Test-retest and image registration analyses.
Shiri I; Hajianfar G; Sohrabi A; Abdollahi H; P Shayesteh S; Geramifar P; Zaidi H; Oveisi M; Rahmim A
Med Phys; 2020 Sep; 47(9):4265-4280. PubMed ID: 32615647
[TBL] [Abstract][Full Text] [Related]
15. Deriving quantitative information from multiparametric MRI via Radiomics: Evaluation of the robustness and predictive value of radiomic features in the discrimination of low-grade versus high-grade gliomas with machine learning.
Ubaldi L; Saponaro S; Giuliano A; Talamonti C; Retico A
Phys Med; 2023 Mar; 107():102538. PubMed ID: 36796177
[TBL] [Abstract][Full Text] [Related]
16. MRI-based radiomics models to assess prostate cancer, extracapsular extension and positive surgical margins.
He D; Wang X; Fu C; Wei X; Bao J; Ji X; Bai H; Xia W; Gao X; Huang Y; Hou J
Cancer Imaging; 2021 Jul; 21(1):46. PubMed ID: 34225808
[TBL] [Abstract][Full Text] [Related]
17. Standardization of brain MR images across machines and protocols: bridging the gap for MRI-based radiomics.
Carré A; Klausner G; Edjlali M; Lerousseau M; Briend-Diop J; Sun R; Ammari S; Reuzé S; Alvarez Andres E; Estienne T; Niyoteka S; Battistella E; Vakalopoulou M; Dhermain F; Paragios N; Deutsch E; Oppenheim C; Pallud J; Robert C
Sci Rep; 2020 Jul; 10(1):12340. PubMed ID: 32704007
[TBL] [Abstract][Full Text] [Related]
18. Phantom study investigating the repeatability of radiomic features with alteration of image acquisition parameters in magnetic resonance imaging.
Mitchell-Hay R; Ahearn T; Murray A; Waiter G
J Med Imaging Radiat Sci; 2024 Mar; 55(1):19-28. PubMed ID: 37932212
[TBL] [Abstract][Full Text] [Related]
19. Influence of image preprocessing on the segmentation-based reproducibility of radiomic features:
Koçak B; Yüzkan S; Mutlu S; Karagülle M; Kala A; Kadıoğlu M; Solak S; Sunman Ş; Temiz ZH; Ganiyusufoğlu AK
Diagn Interv Radiol; 2024 May; 30(3):152-162. PubMed ID: 38073244
[TBL] [Abstract][Full Text] [Related]
20. Repeatability of CBCT radiomic features and their correlation with CT radiomic features for prostate cancer.
Delgadillo R; Spieler BO; Ford JC; Kwon D; Yang F; Studenski M; Padgett KR; Abramowitz MC; Dal Pra A; Stoyanova R; Pollack A; Dogan N
Med Phys; 2021 May; 48(5):2386-2399. PubMed ID: 33598943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
